Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics

Bibliographic Details
Main Authors: Lisa Bartmann, David Schumacher, Saskia von Stillfried, Marieke Sternkopf, Setareh Alampour-Rajabi, Marc A. M. J. van Zandvoort, Fabian Kiessling, Zhuojun Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.617329/full
_version_ 1818928793022103552
author Lisa Bartmann
Lisa Bartmann
David Schumacher
Saskia von Stillfried
Marieke Sternkopf
Setareh Alampour-Rajabi
Marc A. M. J. van Zandvoort
Marc A. M. J. van Zandvoort
Fabian Kiessling
Zhuojun Wu
Zhuojun Wu
author_facet Lisa Bartmann
Lisa Bartmann
David Schumacher
Saskia von Stillfried
Marieke Sternkopf
Setareh Alampour-Rajabi
Marc A. M. J. van Zandvoort
Marc A. M. J. van Zandvoort
Fabian Kiessling
Zhuojun Wu
Zhuojun Wu
author_sort Lisa Bartmann
collection DOAJ
first_indexed 2024-12-20T03:34:33Z
format Article
id doaj.art-1a846cc50c1142b2b15b79d0040ab993
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-20T03:34:33Z
publishDate 2020-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-1a846cc50c1142b2b15b79d0040ab9932022-12-21T19:54:55ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-11-011110.3389/fphar.2020.617329617329Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and TheranosticsLisa Bartmann0Lisa Bartmann1David Schumacher2Saskia von Stillfried3Marieke Sternkopf4Setareh Alampour-Rajabi5Marc A. M. J. van Zandvoort6Marc A. M. J. van Zandvoort7Fabian Kiessling8Zhuojun Wu9Zhuojun Wu10Institute for Experimental Molecular Imaging, University Clinic, RWTH Aachen University, Aachen, GermanyInstitute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, GermanyInstitute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, GermanyInstitute of Pathology, University Clinic, RWTH Aachen University, Aachen, GermanyInstitute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, GermanyInstitute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, GermanyInstitute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, GermanyDepartment of Genetics and Molecular Cell Biology, School for Cardiovascular Diseases (CARIM), School for Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, NetherlandsInstitute for Experimental Molecular Imaging, University Clinic, RWTH Aachen University, Aachen, GermanyInstitute for Experimental Molecular Imaging, University Clinic, RWTH Aachen University, Aachen, GermanyInstitute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, Germanyhttps://www.frontiersin.org/articles/10.3389/fphar.2020.617329/fullriboflavinRFVTtheranosticnanocarriercancer therapytargeting molecules
spellingShingle Lisa Bartmann
Lisa Bartmann
David Schumacher
Saskia von Stillfried
Marieke Sternkopf
Setareh Alampour-Rajabi
Marc A. M. J. van Zandvoort
Marc A. M. J. van Zandvoort
Fabian Kiessling
Zhuojun Wu
Zhuojun Wu
Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics
Frontiers in Pharmacology
riboflavin
RFVT
theranostic
nanocarrier
cancer therapy
targeting molecules
title Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics
title_full Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics
title_fullStr Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics
title_full_unstemmed Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics
title_short Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics
title_sort corrigendum evaluation of riboflavin transporters as targets for drug delivery and theranostics
topic riboflavin
RFVT
theranostic
nanocarrier
cancer therapy
targeting molecules
url https://www.frontiersin.org/articles/10.3389/fphar.2020.617329/full
work_keys_str_mv AT lisabartmann corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics
AT lisabartmann corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics
AT davidschumacher corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics
AT saskiavonstillfried corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics
AT mariekesternkopf corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics
AT setarehalampourrajabi corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics
AT marcamjvanzandvoort corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics
AT marcamjvanzandvoort corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics
AT fabiankiessling corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics
AT zhuojunwu corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics
AT zhuojunwu corrigendumevaluationofriboflavintransportersastargetsfordrugdeliveryandtheranostics